Skip to content

Hyperventilation in Patients With Traumatic Brain Injury

Effects of Moderate Hyperventilation on Cerebral Hemodynamics, Oxygenation and Metabolism in Patients With Severe Traumatic Brain Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03822026
Enrollment
11
Registered
2019-01-30
Start date
2014-05-20
Completion date
2017-05-02
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Injury Trauma, Hyperventilation

Keywords

intracranial pressure, cerebral metabolism, cerebral oxygenation

Brief summary

Elevated intracranial pressure is a dangerous and potentially fatal complication after traumatic brain injury. Hyperventilation is a medical intervention to reduce elevated intracranial pressure by inducing cerebral vasoconstriction, which might be associated to cerebral ischemia and hypoxia. The main hypothesis is that a moderate degree of hyperventilation is sufficient to reduce the intracranial pressure without inducing cerebral ischemia.

Detailed description

In patients with severe traumatic brain injury (TBI), and with intracranial pressure-monitoring, brain tissue oxygen tension and/or microdialysis probes hyperventilation-tests are performed in the acute phase after trauma. Data are collected and TCCD measurements are performed at baseline, at the beginning of moderate hyperventilation, after prolonged moderate hyperventilation (for 50 minutes) and after return to baseline. The present study aims to quantify potential adverse effects of moderate short-term hyperventilation during the acute phase of the severe TBI on cerebral hemodynamics, oxygenation, and metabolism.

Interventions

Increase of the alveolar ventilation by a stepwise increase in tidal volumes and respiratory rate until a reduction of end-tidal CO2 of 0.7 kPa is achieved

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

several parameters are collected at different time points: at baseline conditions, during moderate hyperventilation, and after return to baseline

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* nonpenetrating traumatic brain injury * Glasgow coma scale \<9 at presentation * Intracranial pressure monitoring * brain tissue oxygen tension monitoring and/or microdialysis monitoring * invasive mechanical ventilation with FIO2 \<60% and PEEP \<15 mbar

Exclusion criteria

* decompressive craniectomy * pregnancy * pre-existing neurological disease * previous traumatic brain injury * acute cardiovascular disease * severe respiratory failure * acute on chronic liver disease * sepsis * failure to obtain satisfactory bilateral TCCD signals * persisting hypovolemia or hemodynamic instability

Design outcomes

Primary

MeasureTime frameDescription
intracranial pressure10, 20, 50, 60 minutes after begin of the hyperventilation testChange of intracranial pressure during moderate hyperventilation

Secondary

MeasureTime frameDescription
cerebral Lactate/ Pyruvate ratio1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation testno changes
cerebral flow velocity in the middle cerebral artery20, 50, 60 minutes after begin of the hyperventilation testChange of cerebral flow velocity during moderate hyperventilation
brain tissue oxygenation (PbrO2)10, 20, 50, 60 minutes after begin of the hyperventilation testno changes

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026